Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Exp Gerontol. 2009 Sep 6;44(12):752–759. doi: 10.1016/j.exger.2009.08.012
# days Task Group I
Age: 9.1 (8.2–10.3)
Group II
Age: 9.4 (8.0–11.2)
Group III
Age: 9.2 (7.8–11.1)
Baseline 15 DNMP N=4M/6F
placebo
N=2M/8F
placebo
N=3M/7F
placebo
14 day Wash-in
Single Supplement Phase 129 Landmark N=4M/6F
placebo
N=2M/8F
11mg/kg LA
N=3M/7F
27.5mg/kg ALCAR
14 day Wash-in
Combined Supplement Phase 79 Black/white Discrimination & Reversal N=4M/6F
placebo
N=2M/8F
11mg/kg LA +27.5mg/kg ALCAR
N=3M/7F
27.5mg/kg ALCAR +11mg/kg LA
14 day Wash-out
Wash-out Phase 50 Size Discrimination & Reversal N=4M/6F
placebo
N=2M/8F
placebo
N=2M/7F
placebo